These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1322503)

  • 21. Effect of acetyl-L-carnitine treatment on some behavioural, histochemical and histological parameters of methylazoxymethanol microencephalic rats.
    Amenta F; Cavallotti C; De Rossi M; Bossoni G; Carpi C
    Int J Tissue React; 1986; 8(6):513-26. PubMed ID: 3793387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeated intracerebroventricular administration of beta-amyloid(25-35) to rats decreases muscarinic receptors in cerebral cortex.
    Pavía J; Alberch J; Alvárez I; Toledano A; de Ceballos ML
    Neurosci Lett; 2000 Jan; 278(1-2):69-72. PubMed ID: 10643803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoamine neurotransmitter metabolism in microencephalic rat brain after prenatal methylazoxymethanol treatment.
    Hallman H; Jonsson G
    Brain Res Bull; 1984 Sep; 13(3):383-9. PubMed ID: 6149797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of acute and chronic cholinesterase inhibition with diisopropylfluorophosphate on muscarinic, dopamine, and GABA receptors of the rat striatum.
    Sivam SP; Norris JC; Lim DK; Hoskins B; Ho IK
    J Neurochem; 1983 May; 40(5):1414-22. PubMed ID: 6300336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbachol- and norepinephrine-stimulated phosphoinositide metabolism in rat brain: effect of chronic cholinesterase inhibition.
    Costa LG; Kaylor G; Murphy SD
    J Pharmacol Exp Ther; 1986 Oct; 239(1):32-7. PubMed ID: 3020234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fetally-induced noradrenergic hyperinnervation of cerebral cortex results in persistent down-regulation of beta-receptors.
    Beaulieu M; Coyle JT
    Brain Res; 1982 Aug; 256(4):491-4. PubMed ID: 6290000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased corticotropin-releasing factor receptors in rat cerebral cortex following chronic atropine treatment.
    De Souza EB; Battaglia G
    Brain Res; 1986 Nov; 397(2):401-4. PubMed ID: 3026562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of repeated organophosphate administration on carbachol-stimulated phosphoinositide hydrolysis in the rat brain.
    Mundy WR; Ward TR; Dulchinos VF; Tilson HA
    Pharmacol Biochem Behav; 1993 Jun; 45(2):309-14. PubMed ID: 8392202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmental changes in muscarinic receptor-stimulated phosphoinositide metabolism in rat brain.
    Balduini W; Murphy SD; Costa LG
    J Pharmacol Exp Ther; 1987 May; 241(2):421-7. PubMed ID: 3033215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased diisopropylfluorophosphate-induced toxicity in mu-opioid receptor knockout mice.
    Tien LT; Fan LW; Ma T; Loh HH; Ho IK
    J Neurosci Res; 2004 Oct; 78(2):259-67. PubMed ID: 15378609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscarinic receptor binding and behavioral effects of atropoine following chronic catecholamine depletion or acetylcholinesterase inhibition in rats.
    Schallert T; Overstreet DH; Yamamura HI
    Pharmacol Biochem Behav; 1980 Aug; 13(2):187-92. PubMed ID: 7413689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortico-hippocampal APP and NGF levels are dynamically altered by cholinergic muscarinic antagonist or M1 agonist treatment in normal mice.
    Seo H; Ferree AW; Isacson O
    Eur J Neurosci; 2002 Feb; 15(3):498-506. PubMed ID: 11876777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of neocortical muscarinic receptors: effects of drug treatment and lesions.
    McKinney M; Coyle JT
    J Neurosci; 1982 Jan; 2(1):97-105. PubMed ID: 7054400
    [No Abstract]   [Full Text] [Related]  

  • 34. Interaction of short chain aliphatic alcohols with muscarinic receptor-stimulated phosphoinositide metabolism in cerebral cortex from neonatal and adult rats.
    Candura SM; Balduini W; Costa LG
    Neurotoxicology; 1991; 12(1):23-32. PubMed ID: 1849621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The distribution of serotonergic nerves in microencephalic rats treated prenatally with methylazoxymethanol.
    Kodama Y; Nonaka R; Hagino Y; Watanabe M
    Neurochem Res; 2000 Apr; 25(4):497-501. PubMed ID: 10823582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
    Forray C; el-Fakahany EE
    Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
    Yamada S; Isogai M; Okudaira H; Hayashi E
    J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spatial memory impairment and central muscarinic receptor loss following prolonged treatment with organophosphates.
    McDonald BE; Costa LG; Murphy SD
    Toxicol Lett; 1988 Jan; 40(1):47-56. PubMed ID: 3341049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-selectivity of amitriptyline for subtypes of brain muscarinic receptors demonstrated in binding and functional assays.
    McKinney M; Lee NH; Anderson DJ; Vella-Rountree L; el-Fakahany EE
    Eur J Pharmacol; 1988 Nov; 157(1):51-60. PubMed ID: 2853074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological characterization of the novel cholinomimetic L-689,660 at cloned and native brain muscarinic receptors.
    Aagaard P; McKinney M
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1478-83. PubMed ID: 8263809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.